Big news dropped this week: the federal government is moving forward with cannabis rescheduling, shifting weed from Schedule I to Schedule III of the Controlled Substances Act. If you’ve been following the cannabis legalization debate at all, you know this is a huge deal.

But let’s slow down for a second, because “huge deal” doesn’t mean what a lot of people think it means.

Schedule III Is Still Not Legalization

We’ll say it plainly: this is not federal cannabis legalization. Cannabis will still be federally controlled. You still can’t walk into a federally licensed store and buy a joint. Interstate cannabis commerce is still illegal. Nobody’s criminal record gets wiped.

What changes is the federal government officially acknowledging that cannabis has legitimate medical value: something patients, researchers, and, honestly, most Americans have known for years. The Schedule I label put cannabis in the same category as heroin, which was always a stretch. Schedule III puts it alongside drugs like ketamine: controlled, yes, but medically recognized.

The other concrete change? If rescheduling is finalized, it would likely end the IRS 280E tax penalty that’s been crushing cannabis businesses for years. Under 280E, plant-touching cannabis companies can’t deduct normal business expenses: rent, payroll, and utilities from their federal taxes. Ending that would be a massive win for independent operators.

Snapdragon & The Hemp Market Have Been Ready for This Moment

While federal policy has been stuck in neutral for years, the legal hemp market built something real in the meantime. Products like THCA flower, delta-9 THC gummies, and delta-8 concentrates found a way to deliver genuine cannabis experiences within the existing legal framework. And they’ve been doing it with real transparency: third-party lab results, clear cannabinoid profiles, honest terpene data.

At Snapdragon, that’s been the standard from day one. We’re a Chattanooga-based cannabis company that started in 2016 because we believed people deserved access to quality cannabis products, not mystery bags with no accountability.

Rescheduling is the federal government finally catching up to what the hemp market figured out a long time ago.

What to Reach For Right Now

In short, it has still never been a better time to buy hemp. If you’re new to hemp-derived cannabis or just curious what the current market actually looks like, here’s a quick breakdown of what people are reaching for:

For the flower experience, our THCA 1-Gram Pre-Rolls are a great starting point. Strains like Super Runtz and MAC deliver an uplifting, euphoric experience, while options like White Runtz and Gelato #41 lean more toward relaxation. These are made from high-THCA hemp flower and come in at $7–$12 a piece, an easy way to explore without committing to a full eighth.

If you want something that hits harder and cleaner, the THCA Connoisseur Pre-Rolls with Kief and Live Resin are where things get serious. Rolled in kief and coated with live resin, strains like Oregon Diesel (energize) and Banana Zkittles (restful) show what happens when flower and concentrate come together. These are for people who already know what they like.

Rather eat or drink your cannabis? The Delta-9 THC Live Resin Infused Gummies are one of our most popular products for a reason. Live resin means a fuller cannabinoid and terpene profile than standard distillate gummies. You actually feel the difference. Starting at $4.99, they’re also a low-risk way to figure out your dose.

Check out our fast-acting NANO infused beverages like Canna Bliss, Dam Water, Doobie Blast, and more that start acting in minutes rather than hours like traditional edibles.

And if you’re into concentrates, the THCA Live Resin Concentrate lineup has something for every session. Cali Chem Crumble for a sativa-forward energize, Runtz Badder for a hybrid euphoric, or Grandaddy Purple Badder when you just need to unwind. Dabbers know what to do with these and you can get started dabbing in the same order if you grab a Lil Dabbie Disposable Device.

The Bottom Line

Federal cannabis rescheduling is real progress but it is not the answer to all of our issues. The 280E relief alone could reshape what independent cannabis businesses look like in this country. And the formal recognition of cannabis as medically valuable finally matches the reality that millions of people have been living for years.

But full legalization? Banking reform? Interstate commerce? That work is still ahead.

In the meantime, the hemp market keeps doing what it’s been doing: growing, improving, and giving people access to quality cannabis experiences right now, not whenever Washington gets around to it.

All our products are third-party lab tested. You can view results anytime.

Shop the full lineup at snapdragonhemp.com and RINS9.com.